APO Research
Talk to an analyst

APO RESEARCH · REPORT

Empagliflozin Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Empagliflozin Drug Industry Growth and Trends Forecast to 2032

23 December 2025104 pages

Choose your research edition.

Industry ResearchEmpagliflozin Drug Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Empagliflozin Drug Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Empagliflozin Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Empagliflozin Drug Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Empagliflozin Drug Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Empagliflozin Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Empagliflozin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Empagliflozin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Empagliflozin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Empagliflozin Drug include Zhengda Tianqing, Sichuan Kelun Pharmaceutical, Jiangsu Wanbang, Jiangsu Hausen, PARANOVA PACK, OriFarm, Lupin Laboratories, EurimPharm Arzneimittel and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Empagliflozin Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Empagliflozin Drug market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Empagliflozin Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Empagliflozin Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Empagliflozin Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Empagliflozin Drug Market by Company

Zhengda Tianqing

Sichuan Kelun Pharmaceutical

Jiangsu Wanbang

Jiangsu Hausen

PARANOVA PACK

OriFarm

Lupin Laboratories

EurimPharm Arzneimittel

Boehringer Ingelheim

ABACUS MEDICINE

Empagliflozin Drug Segment by Type

Single-ingredient

Combination

Empagliflozin Drug Segment by Application

Hospitals

Retail Pharmacy

Others

Empagliflozin Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Empagliflozin Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Empagliflozin Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Empagliflozin Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Empagliflozin Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Empagliflozin Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Single-ingredient Table 2. Major Company of Combination Table 3. Global Empagliflozin Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Empagliflozin Drug Sales by Type (2021-2026) & (k units) Table 5. Global Empagliflozin Drug Sales Market Share in Volume by Type (2021-2026) Table 6. Global Empagliflozin Drug Sales by Type (2021-2026) & (US$ Million) Table 7. Global Empagliflozin Drug Sales Market Share in Value by Type (2021-2026) Table 8. Global Empagliflozin Drug Price by Type (2021-2026) & (USD/unit) Table 9. Global Empagliflozin Drug Sales by Type (2027-2032) & (k units) Table 10. Global Empagliflozin Drug Sales Market Share in Volume by Type (2027-2032) Table 11. Global Empagliflozin Drug Sales by Type (2027-2032) & (US$ Million) Table 12. Global Empagliflozin Drug Sales Market Share in Value by Type (2027-2032) Table 13. Global Empagliflozin Drug Price by Type (2027-2032) & (USD/unit) Table 14. North America Empagliflozin Drug Sales by Type (2021-2026) & (k units) Table 15. North America Empagliflozin Drug Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Empagliflozin Drug Sales by Type (2021-2026) & (k units) Table 17. Europe Empagliflozin Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Empagliflozin Drug Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Empagliflozin Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Empagliflozin Drug Sales by Type (2021-2026) & (k units) Table 21. Latin America Empagliflozin Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Empagliflozin Drug Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Empagliflozin Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Empagliflozin Drug Industry Trends Table 25. Empagliflozin Drug Industry Drivers Table 26. Empagliflozin Drug Industry Opportunities and Challenges Table 27. Empagliflozin Drug Industry Restraints Table 28. Global Empagliflozin Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Empagliflozin Drug Revenue Market Share by Company (2021-2026) Table 30. Global Empagliflozin Drug Sales by Company (2021-2026) & (k units) Table 31. Global Empagliflozin Drug Sales Share by Company (2021-2026) Table 32. Global Empagliflozin Drug Market Price by Company (2021-2026) & (USD/unit) Table 33. Global Empagliflozin Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Empagliflozin Drug Major Company Production Sites and Headquarters Table 35. Global Empagliflozin Drug Company, Product Type & Application Table 36. Global Empagliflozin Drug Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Empagliflozin Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Empagliflozin Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Empagliflozin Drug Sales by Region (2021-2026) & (k units) Table 41. Global Empagliflozin Drug Sales Market Share in Volume by Region (2021-2026) Table 42. Global Empagliflozin Drug Sales by Region (2021-2026) & (US$ Million) Table 43. Global Empagliflozin Drug Sales Market Share in Value by Region (2021-2026) Table 44. Global Empagliflozin Drug Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 45. Global Empagliflozin Drug Sales by Region (2027-2032) & (k units) Table 46. Global Empagliflozin Drug Sales Market Share in Volume by Region (2027-2032) Table 47. Global Empagliflozin Drug Sales by Region (2027-2032) & (US$ Million) Table 48. Global Empagliflozin Drug Sales Market Share in Value by Region (2027-2032) Table 49. Global Empagliflozin Drug Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 50. Global Empagliflozin Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Empagliflozin Drug Sales by Application (2021-2026) & (k units) Table 52. Global Empagliflozin Drug Sales Market Share in Volume by Application (2021-2026) Table 53. Global Empagliflozin Drug Sales by Application (2021-2026) & (US$ Million) Table 54. Global Empagliflozin Drug Sales Market Share in Value by Application (2021-2026) Table 55. Global Empagliflozin Drug Price by Application (2021-2026) & (USD/unit) Table 56. Global Empagliflozin Drug Sales by Application (2027-2032) & (k units) Table 57. Global Empagliflozin Drug Sales Market Share in Volume by Application (2027-2032) Table 58. Global Empagliflozin Drug Sales by Application (2027-2032) & (US$ Million) Table 59. Global Empagliflozin Drug Sales Market Share in Value by Application (2027-2032) Table 60. Global Empagliflozin Drug Price by Application (2027-2032) & (USD/unit) Table 61. North America Empagliflozin Drug Sales by Application (2021-2026) & (k units) Table 62. North America Empagliflozin Drug Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Empagliflozin Drug Sales by Application (2021-2026) & (k units) Table 64. Europe Empagliflozin Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Empagliflozin Drug Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Empagliflozin Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Empagliflozin Drug Sales by Application (2021-2026) & (k units) Table 68. Latin America Empagliflozin Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Empagliflozin Drug Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Empagliflozin Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Zhengda Tianqing Company Information Table 72. Zhengda Tianqing Business Overview Table 73. Zhengda Tianqing Empagliflozin Drug Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. Zhengda Tianqing Empagliflozin Drug Product Portfolio Table 75. Zhengda Tianqing Recent Development Table 76. Sichuan Kelun Pharmaceutical Company Information Table 77. Sichuan Kelun Pharmaceutical Business Overview Table 78. Sichuan Kelun Pharmaceutical Empagliflozin Drug Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Sichuan Kelun Pharmaceutical Empagliflozin Drug Product Portfolio Table 80. Sichuan Kelun Pharmaceutical Recent Development Table 81. Jiangsu Wanbang Company Information Table 82. Jiangsu Wanbang Business Overview Table 83. Jiangsu Wanbang Empagliflozin Drug Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Jiangsu Wanbang Empagliflozin Drug Product Portfolio Table 85. Jiangsu Wanbang Recent Development Table 86. Jiangsu Hausen Company Information Table 87. Jiangsu Hausen Business Overview Table 88. Jiangsu Hausen Empagliflozin Drug Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Jiangsu Hausen Empagliflozin Drug Product Portfolio Table 90. Jiangsu Hausen Recent Development Table 91. PARANOVA PACK Company Information Table 92. PARANOVA PACK Business Overview Table 93. PARANOVA PACK Empagliflozin Drug Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. PARANOVA PACK Empagliflozin Drug Product Portfolio Table 95. PARANOVA PACK Recent Development Table 96. OriFarm Company Information Table 97. OriFarm Business Overview Table 98. OriFarm Empagliflozin Drug Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. OriFarm Empagliflozin Drug Product Portfolio Table 100. OriFarm Recent Development Table 101. Lupin Laboratories Company Information Table 102. Lupin Laboratories Business Overview Table 103. Lupin Laboratories Empagliflozin Drug Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Lupin Laboratories Empagliflozin Drug Product Portfolio Table 105. Lupin Laboratories Recent Development Table 106. EurimPharm Arzneimittel Company Information Table 107. EurimPharm Arzneimittel Business Overview Table 108. EurimPharm Arzneimittel Empagliflozin Drug Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. EurimPharm Arzneimittel Empagliflozin Drug Product Portfolio Table 110. EurimPharm Arzneimittel Recent Development Table 111. Boehringer Ingelheim Company Information Table 112. Boehringer Ingelheim Business Overview Table 113. Boehringer Ingelheim Empagliflozin Drug Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Boehringer Ingelheim Empagliflozin Drug Product Portfolio Table 115. Boehringer Ingelheim Recent Development Table 116. ABACUS MEDICINE Company Information Table 117. ABACUS MEDICINE Business Overview Table 118. ABACUS MEDICINE Empagliflozin Drug Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. ABACUS MEDICINE Empagliflozin Drug Product Portfolio Table 120. ABACUS MEDICINE Recent Development Table 121. North America Empagliflozin Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 122. North America Empagliflozin Drug Sales by Country (2021-2026) & (k units) Table 123. North America Empagliflozin Drug Sales Market Share by Country (2021-2026) Table 124. North America Empagliflozin Drug Sales Forecast by Country (2027-2032) & (k units) Table 125. North America Empagliflozin Drug Sales Market Share Forecast by Country (2027-2032) Table 126. North America Empagliflozin Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Empagliflozin Drug Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Empagliflozin Drug Market Share by Country (2021-2026) Table 129. North America Empagliflozin Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Empagliflozin Drug Market Share Forecast by Country (2027-2032) Table 131. Europe Empagliflozin Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. Europe Empagliflozin Drug Sales by Country (2021-2026) & (k units) Table 133. Europe Empagliflozin Drug Sales Market Share by Country (2021-2026) Table 134. Europe Empagliflozin Drug Sales Forecast by Country (2027-2032) & (k units) Table 135. Europe Empagliflozin Drug Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Empagliflozin Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Empagliflozin Drug Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Empagliflozin Drug Market Share by Country (2021-2026) Table 139. Europe Empagliflozin Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Empagliflozin Drug Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Empagliflozin Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Empagliflozin Drug Sales by Country (2021-2026) & (k units) Table 143. Asia-Pacific Empagliflozin Drug Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Empagliflozin Drug Sales Forecast by Country (2027-2032) & (k units) Table 145. Asia-Pacific Empagliflozin Drug Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Empagliflozin Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Empagliflozin Drug Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Empagliflozin Drug Market Share by Country (2021-2026) Table 149. Asia-Pacific Empagliflozin Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Empagliflozin Drug Market Share Forecast by Country (2027-2032) Table 151. Latin America Empagliflozin Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Latin America Empagliflozin Drug Sales by Country (2021-2026) & (k units) Table 153. Latin America Empagliflozin Drug Sales Market Share by Country (2021-2026) Table 154. Latin America Empagliflozin Drug Sales Forecast by Country (2027-2032) & (k units) Table 155. Latin America Empagliflozin Drug Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Empagliflozin Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Empagliflozin Drug Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Empagliflozin Drug Market Share by Country (2021-2026) Table 159. Latin America Empagliflozin Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Empagliflozin Drug Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Empagliflozin Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Empagliflozin Drug Sales by Country (2021-2026) & (k units) Table 163. Middle East and Africa Empagliflozin Drug Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Empagliflozin Drug Sales Forecast by Country (2027-2032) & (k units) Table 165. Middle East and Africa Empagliflozin Drug Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Empagliflozin Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Empagliflozin Drug Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Empagliflozin Drug Market Share by Country (2021-2026) Table 169. Middle East and Africa Empagliflozin Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Empagliflozin Drug Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Empagliflozin Drug Distributors List Table 174. Empagliflozin Drug Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Empagliflozin Drug Image Figure 2. Global Empagliflozin Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Empagliflozin Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Empagliflozin Drug Sales (2021-2032) & (k units) Figure 5. Single-ingredient Image Figure 6. Global Single-ingredient Sales YoY Growth (2021-2032) & (k units) Figure 7. Combination Image Figure 8. Global Combination Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Empagliflozin Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Empagliflozin Drug Market Share by Type 2025 VS 2032 Figure 11. North America Empagliflozin Drug Sales Market Share in Volume by Type in 2025 Figure 12. North America Empagliflozin Drug Sales Market Share in Value by Type in 2025 Figure 13. Europe Empagliflozin Drug Sales Market Share in Volume by Type in 2025 Figure 14. Europe Empagliflozin Drug Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Empagliflozin Drug Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Empagliflozin Drug Sales Market Share in Value by Type in 2025 Figure 17. Latin America Empagliflozin Drug Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Empagliflozin Drug Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Empagliflozin Drug Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Empagliflozin Drug Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Empagliflozin Drug Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospitals Image Figure 24. Global Hospitals Sales YoY Growth (2021-2032) & (k units) Figure 25. Retail Pharmacy Image Figure 26. Global Retail Pharmacy Sales YoY Growth (2021-2032) & (k units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Empagliflozin Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Empagliflozin Drug Market Share by Application 2025 VS 2032 Figure 31. North America Empagliflozin Drug Sales Market Share in Volume by Application in 2025 Figure 32. North America Empagliflozin Drug Sales Market Share in Value by Application in 2025 Figure 33. Europe Empagliflozin Drug Sales Market Share in Volume by Application in 2025 Figure 34. Europe Empagliflozin Drug Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Empagliflozin Drug Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Empagliflozin Drug Sales Market Share in Value by Application in 2025 Figure 37. Latin America Empagliflozin Drug Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Empagliflozin Drug Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Empagliflozin Drug Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Empagliflozin Drug Sales Market Share in Value by Application in 2025 Figure 41. North America Empagliflozin Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Empagliflozin Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Empagliflozin Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Empagliflozin Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Empagliflozin Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Empagliflozin Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Empagliflozin Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Empagliflozin Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Empagliflozin Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Empagliflozin Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Empagliflozin Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Empagliflozin Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Empagliflozin Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Empagliflozin Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Empagliflozin Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Empagliflozin Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Empagliflozin Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Empagliflozin Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Empagliflozin Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Empagliflozin Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Empagliflozin Drug Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Empagliflozin Drug Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Single-ingredient
  • Combination
Applications
  • Hospitals
  • Retail Pharmacy
  • Others
Companies covered
  • Zhengda Tianqing
  • Sichuan Kelun Pharmaceutical
  • Jiangsu Wanbang
  • Jiangsu Hausen
  • PARANOVA PACK
  • OriFarm
  • Lupin Laboratories
  • EurimPharm Arzneimittel
  • Boehringer Ingelheim
  • ABACUS MEDICINE

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Empagliflozin Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Empagliflozin Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Empagliflozin Drug Market by Type
  6. 1.3.1 Single-ingredient
  7. 1.3.2 Combination
  8. 1.4 Global Empagliflozin Drug Market Size by Type
  9. 1.4.1 Global Empagliflozin Drug Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Empagliflozin Drug Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Empagliflozin Drug Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Empagliflozin Drug Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Empagliflozin Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Empagliflozin Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Empagliflozin Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Empagliflozin Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Empagliflozin Drug Industry Trends
  2. 2.2 Empagliflozin Drug Industry Drivers
  3. 2.3 Empagliflozin Drug Industry Opportunities and Challenges
  4. 2.4 Empagliflozin Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Empagliflozin Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Empagliflozin Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Empagliflozin Drug Price (2021-2026)
  4. 3.4 Global Empagliflozin Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Empagliflozin Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Empagliflozin Drug Company, Product Type & Application
  7. 3.7 Global Empagliflozin Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Empagliflozin Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Empagliflozin Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Empagliflozin Drug Tier 1, Tier 2, and Tier 3
4 Empagliflozin Drug Regional Status and Outlook
  1. 4.1 Global Empagliflozin Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Empagliflozin Drug Historic Market Size by Region
  3. 4.2.1 Global Empagliflozin Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Empagliflozin Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Empagliflozin Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Empagliflozin Drug Forecasted Market Size by Region
  7. 4.3.1 Global Empagliflozin Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Empagliflozin Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Empagliflozin Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Empagliflozin Drug by Application
  1. 5.1 Empagliflozin Drug Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Retail Pharmacy
  4. 5.1.3 Others
  5. 5.2 Global Empagliflozin Drug Market Size by Application
  6. 5.2.1 Global Empagliflozin Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Empagliflozin Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Empagliflozin Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Empagliflozin Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Empagliflozin Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Empagliflozin Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Empagliflozin Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Empagliflozin Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zhengda Tianqing
  2. 6.1.1 Zhengda Tianqing Company Information
  3. 6.1.2 Zhengda Tianqing Business Overview
  4. 6.1.3 Zhengda Tianqing Empagliflozin Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zhengda Tianqing Empagliflozin Drug Product Portfolio
  6. 6.1.5 Zhengda Tianqing Recent Developments
  7. 6.2 Sichuan Kelun Pharmaceutical
  8. 6.2.1 Sichuan Kelun Pharmaceutical Company Information
  9. 6.2.2 Sichuan Kelun Pharmaceutical Business Overview
  10. 6.2.3 Sichuan Kelun Pharmaceutical Empagliflozin Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sichuan Kelun Pharmaceutical Empagliflozin Drug Product Portfolio
  12. 6.2.5 Sichuan Kelun Pharmaceutical Recent Developments
  13. 6.3 Jiangsu Wanbang
  14. 6.3.1 Jiangsu Wanbang Company Information
  15. 6.3.2 Jiangsu Wanbang Business Overview
  16. 6.3.3 Jiangsu Wanbang Empagliflozin Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Jiangsu Wanbang Empagliflozin Drug Product Portfolio
  18. 6.3.5 Jiangsu Wanbang Recent Developments
  19. 6.4 Jiangsu Hausen
  20. 6.4.1 Jiangsu Hausen Company Information
  21. 6.4.2 Jiangsu Hausen Business Overview
  22. 6.4.3 Jiangsu Hausen Empagliflozin Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Jiangsu Hausen Empagliflozin Drug Product Portfolio
  24. 6.4.5 Jiangsu Hausen Recent Developments
  25. 6.5 PARANOVA PACK
  26. 6.5.1 PARANOVA PACK Company Information
  27. 6.5.2 PARANOVA PACK Business Overview
  28. 6.5.3 PARANOVA PACK Empagliflozin Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 PARANOVA PACK Empagliflozin Drug Product Portfolio
  30. 6.5.5 PARANOVA PACK Recent Developments
  31. 6.6 OriFarm
  32. 6.6.1 OriFarm Company Information
  33. 6.6.2 OriFarm Business Overview
  34. 6.6.3 OriFarm Empagliflozin Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 OriFarm Empagliflozin Drug Product Portfolio
  36. 6.6.5 OriFarm Recent Developments
  37. 6.7 Lupin Laboratories
  38. 6.7.1 Lupin Laboratories Company Information
  39. 6.7.2 Lupin Laboratories Business Overview
  40. 6.7.3 Lupin Laboratories Empagliflozin Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Lupin Laboratories Empagliflozin Drug Product Portfolio
  42. 6.7.5 Lupin Laboratories Recent Developments
  43. 6.8 EurimPharm Arzneimittel
  44. 6.8.1 EurimPharm Arzneimittel Company Information
  45. 6.8.2 EurimPharm Arzneimittel Business Overview
  46. 6.8.3 EurimPharm Arzneimittel Empagliflozin Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 EurimPharm Arzneimittel Empagliflozin Drug Product Portfolio
  48. 6.8.5 EurimPharm Arzneimittel Recent Developments
  49. 6.9 Boehringer Ingelheim
  50. 6.9.1 Boehringer Ingelheim Company Information
  51. 6.9.2 Boehringer Ingelheim Business Overview
  52. 6.9.3 Boehringer Ingelheim Empagliflozin Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Boehringer Ingelheim Empagliflozin Drug Product Portfolio
  54. 6.9.5 Boehringer Ingelheim Recent Developments
  55. 6.10 ABACUS MEDICINE
  56. 6.10.1 ABACUS MEDICINE Company Information
  57. 6.10.2 ABACUS MEDICINE Business Overview
  58. 6.10.3 ABACUS MEDICINE Empagliflozin Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 ABACUS MEDICINE Empagliflozin Drug Product Portfolio
  60. 6.10.5 ABACUS MEDICINE Recent Developments
7 North America by Country
  1. 7.1 North America Empagliflozin Drug Sales by Country
  2. 7.1.1 North America Empagliflozin Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Empagliflozin Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Empagliflozin Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Empagliflozin Drug Market Size by Country
  6. 7.2.1 North America Empagliflozin Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Empagliflozin Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Empagliflozin Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Empagliflozin Drug Sales by Country
  2. 8.1.1 Europe Empagliflozin Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Empagliflozin Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Empagliflozin Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Empagliflozin Drug Market Size by Country
  6. 8.2.1 Europe Empagliflozin Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Empagliflozin Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Empagliflozin Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Empagliflozin Drug Sales by Country
  2. 9.1.1 Asia-Pacific Empagliflozin Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Empagliflozin Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Empagliflozin Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Empagliflozin Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Empagliflozin Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Empagliflozin Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Empagliflozin Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Empagliflozin Drug Sales by Country
  2. 10.1.1 South America Empagliflozin Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Empagliflozin Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Empagliflozin Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Empagliflozin Drug Market Size by Country
  6. 10.2.1 South America Empagliflozin Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Empagliflozin Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Empagliflozin Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Empagliflozin Drug Sales by Country
  2. 11.1.1 Middle East and Africa Empagliflozin Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Empagliflozin Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Empagliflozin Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Empagliflozin Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Empagliflozin Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Empagliflozin Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Empagliflozin Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Empagliflozin Drug Value Chain Analysis
  2. 12.1.1 Empagliflozin Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Empagliflozin Drug Production Mode & Process
  7. 12.2 Empagliflozin Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Empagliflozin Drug Distributors
  10. 12.2.3 Empagliflozin Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst